Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns
- 1 June 2010
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (6), 519-523
- https://doi.org/10.1016/j.ijantimicag.2009.12.017
Abstract
No abstract availableKeywords
Funding Information
- CNRS
This publication has 61 references indexed in Scilit:
- The p160 ER co-regulators predict outcome in ER negative breast cancerBreast Cancer Research and Treatment, 2011
- Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifenBreast Cancer Research and Treatment, 2010
- AIB1 is a predictive factor for tamoxifen response in premenopausal womenAnnals of Oncology, 2010
- The replisome uses mRNA as a primer after colliding with RNA polymeraseNature, 2008
- Uncovering New Metabolic Capabilities of Bacillus subtilis Using Phenotype Profiling of Rifampin-Resistant rpoB MutantsJournal of Bacteriology, 2008
- Antibiotics as signalling moleculesPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2007
- Contribution ofrpoB2RNA Polymerase β Subunit Gene to Rifampin Resistance inNocardiaSpeciesAntimicrobial Agents and Chemotherapy, 2006
- Endocrine-responsive breast cancer and strategies for combating resistanceNature Reviews Cancer, 2002
- Differential inhibition of transcription from σ70‐ and σ32‐dependent promoters by rifampicinFEBS Letters, 1998
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997